• Clozapine N-oxide: Precision Chemogenetic Control in Neurosc

  2026-05-03

  Clozapine N-oxide (CNO) empowers researchers to non-invasively modulate neuronal circuits with unmatched selectivity, making it indispensable for DREADDs-based studies and GPCR signaling research. This article demystifies experimental workflows, uncovers troubleshooting strategies, and leverages insights from recent literature to maximize the reliability of CNO-driven assays.

• RAB31 Orchestrates ESCRT-Independent Exosome Biogenesis Path

  2026-05-02

  This study uncovers RAB31 as a key regulator of an ESCRT-independent exosome pathway, demonstrating its dual roles in ILV formation and in preventing MVE degradation. The findings clarify mechanisms of exosome biogenesis and inform experimental strategies for studying membrane trafficking.

• SB743921 (SKU B1590): Reliable KSP Inhibitor for Cancer Assa

  2026-05-01

  This article provides a scenario-driven, evidence-based exploration of SB743921 (SKU B1590) as a potent and selective kinesin spindle protein inhibitor for cancer research. Drawing on validated protocols and peer-reviewed literature, we detail how SB743921 addresses practical challenges in cell viability, proliferation, and cytotoxicity assays, offering researchers enhanced reliability and reproducibility in preclinical workflows.

• Honokiol Triggers Paraptosis-Like Cell Death in APL via mTOR

  2026-05-01

  This study demonstrates that honokiol induces a non-apoptotic, paraptosis-like cell death in acute promyelocytic leukemia (APL) cells through activation of mTOR and MAPK signaling pathways. The findings provide mechanistic insight into alternative cell death modalities in APL and suggest new therapeutic targets for cases resistant to conventional apoptosis-inducing treatments.

• In Vitro Activity of Midecamycin: Macrolide Efficacy and Lim

  2026-04-30

  This study systematically evaluates midecamycin, a novel acetoxy-substituted macrolide antibiotic, for its in vitro activity against a spectrum of gram-positive and gram-negative bacteria. Results clarify midecamycin’s comparative potency, spectrum, and limitations—offering insights critical for researchers in antibiotic development and resistance profiling.

• AM 281: Potent CB1 Cannabinoid Receptor Antagonist Overview

  2026-04-30

  AM 281 is a highly selective CB1 cannabinoid receptor antagonist with nanomolar affinity, making it an essential tool for memory impairment research and neuropharmacology applications. Evidence supports its role in reversing cognitive deficits and modulating the CB1-CREB-GLT-1 axis in traumatic brain injury models.

• LY-411575: Precision γ-Secretase Inhibition for Translationa

  2026-04-29

  Explore the scientific depth of LY-411575, a leading gamma-secretase inhibitor, with an emphasis on assay design, nuanced pathway modulation, and critical evaluation of recent evidence. This article uniquely bridges bench protocols with translational decision-making in Alzheimer's and cancer research.

• Sulfo-NHS-SS-Biotin: Mechanistic Insights and Protocol Preci

  2026-04-29

  Explore the mechanistic depth of Sulfo-NHS-SS-Biotin as a biotin disulfide N-hydroxysulfosuccinimide ester for precise protein labeling. This article uniquely bridges biochemical mechanism, rigorous protocol design, and translational relevance, setting a new standard for reliable biotinylation in advanced affinity workflows.

• NAD+ as a Regulatory Nexus: Beyond Energy to DNA Damage Resp

  2026-04-28

  Explore the multifaceted roles of Nicotinamide Adenine Dinucleotide (NAD+) in cellular stress adaptation, DNA damage response, and autophagy. This article delivers new insights for researchers using NAD+ in advanced metabolic signaling assays, with a unique focus on linking recent caspase research to practical applications.

• Levofloxacin in Research: Beyond Antibacterial Activity

  2026-04-28

  Explore Levofloxacin—a synthetic fluoroquinolone antibiotic—through the lens of its multifaceted use in laboratory research, including DNA replication inhibition, osteoblast function, and cartilage metabolism. This article delivers advanced insights and practical guidance distinct from existing resources.

• Tunable Human Intestinal Organoids: Balancing Self-Renewal a

  2026-04-27

  This study introduces a human intestinal organoid culture system that finely balances stem cell self-renewal and differentiation by leveraging combinations of small molecule modulators. The platform increases cellular diversity and proliferative capacity under a single condition, streamlining organoid scalability for disease modeling and high-throughput applications.

• Metoprolol as a Selective Beta1-Adrenoceptor Antagonist in R

  2026-04-27

  Metoprolol enables researchers to probe cardiovascular, inflammatory, and oncological mechanisms with precision. This guide details practical workflows, advanced applications, and troubleshooting strategies, leveraging new pharmacokinetic insights to optimize experimental outcomes.

• Reliable Apoptosis Detection with Annexin V-Cy5/DAPI Kit (K2

  2026-04-26

  This article guides biomedical researchers through common cell apoptosis assay pitfalls and demonstrates how the Annexin V-Cy5/DAPI Apoptosis Kit (SKU K2255) from APExBIO addresses real-world laboratory challenges. By exploring experimental design, protocol optimization, and product selection, we provide evidence-based insights to enhance workflow reliability and data interpretability.

• Tunable Human Intestinal Organoids: Balancing Renewal and Di

  2026-04-25

  This study pioneers a human intestinal organoid culture system that enables precise, reversible control over stem cell self-renewal and differentiation using small molecule modulators. The findings provide a scalable platform with enhanced cellular diversity, addressing limitations of traditional organoid methods and facilitating high-throughput biomedical research.

• GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Modula

  2026-04-24

  The referenced study elucidates how upregulation of glutamate transporter 1 (GLT-1) in astrocytes attenuates neuronal apoptosis and cognitive dysfunction after traumatic brain injury (TBI), primarily through inhibition of the CB1-CREB signaling pathway. The findings highlight a mechanistic link between endocannabinoid signaling, astrocytic glutamate clearance, and neuroprotection, offering new experimental strategies for memory impairment research.

11329 records 1/756 page Next 12345 下5页 Last page